LB Pharmaceuticals is a New York drug developer focused on LB-102, a candidate for schizophrenia and mood disorders. It last closed at $38.85 on Nov 20, down 2.97% on the day. The next earnings report for LBRX is expected around Thu, Mar 25, 2027, after the close. For the quarter ended Sep 2026, LBRX reported EPS of -$1.79. Over its last 5 reports the stock moved an average of 4.5% the session after earnings.
AI Auto Pilots
Is LBRX in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold LBRX.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on LBRXStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
LBRX · as of the Nov 20 close · updated each morning
Pullback inside a longer uptrend
The stock is 6% below its 20 day and 2% below its 50 day average. It is 12% above its 200 day average, so the longer trend is still up. Momentum is weak (RSI 44). The nearest support is the Pivot S1 at $38.06, and the nearest resistance the swing high (Sep 30) at $39.23.
Short trendBearish
Long trendBullish
MomentumWeak
StretchNormal
VolatilityNormal, 6.8%/day
Key levels
$50.1652 week high+29.1%
$41.0720 day average+5.7%
$40.59100 day average+4.5%
$40.16Pivot R1+3.4%
$39.4950 day average+1.6%
$39.36Pivot+1.3%
$39.23Swing high (Sep 30)+1.0%
$38.85Last close
$38.06Pivot S1−2.0%
$37.98Swing low (Nov 5)−2.2%
$34.04200 day average−12.4%
$15.1952 week low−60.9%
Indicators
RSI (14)
43.78
Middle of its range
Neutral
MACD
0.32
Below its signal line
Bearish
Stochastic
21.4
Middle of its range
Neutral
ADX (14)
22.5
Weak trend
Williams %R
-88.9
Oversold below −80, overbought above −20
Oversold
CCI (20)
-73.9
Oversold below −100, overbought above 100
Neutral
Rate of change
−7.5%
Change over 10 sessions
Bearish
ATR (14)
$2.66
Typical daily range, 6.8% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Above
Rising
Short trendBullish
Long trendNot enough history
MomentumFading
StretchNormal
VolatilityNormal, 11.4%/day
Key levels
$50.1652 week high+29.1%
$41.0720 day average+5.7%
$40.59100 day average+4.5%
$40.16Pivot R1+3.4%
$39.4950 day average+1.6%
$39.36Pivot+1.3%
$39.23Swing high (Sep 30)+1.0%
$38.85Last close
$38.06Pivot S1−2.0%
$37.98Swing low (Nov 5)−2.2%
$34.04200 day average−12.4%
$15.1952 week low−60.9%
Indicators
RSI (14)
52.52
Middle of its range
Neutral
MACD
2.38
Below its signal line
Bearish
Stochastic
47.9
Middle of its range
Neutral
ADX (14)
28.4
Trending up
Williams %R
-66.4
Oversold below −80, overbought above −20
Neutral
CCI (20)
-4.8
Oversold below −100, overbought above 100
Neutral
Rate of change
−12.9%
Change over 10 sessions
Bearish
ATR (14)
$4.44
Typical daily range, 11.4% of price
MA 10Below
MA 20Below
MA 50Above
MA 100–
MA 200–
What happened before, for LBRX
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how LBRX did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for LBRXHow many large options trades hit LBRX, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in LBRX in the last 90 days.
From SEC Form 4 filings by LBRX's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether LBRX is in one of them and how their past LBRX trades turned out.
LB Pharmaceuticals is a biopharmaceutical company based in New York that develops treatments for neuropsychiatric disorders. Its main product candidate, LB-102, is in late-stage testing for schizophrenia and bipolar depression, with a planned study in major depressive disorder as a supplemental treatment. LB-102 is a chemical relative of amisulpride, an antipsychotic already used in many countries outside the United States. The company aims to offer its treatments to patients and to the psychiatrists who prescribe for them.